Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel M Aebersold

Showing results (1-10 of 214) with videos related to

Pageof 22
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|February 5, 2009
Potential and future strategies for radiotherapy in hepatocellular carcinomaDaniel M Aebersold
Praxis|October 17, 2013
[Extracranial stereotactic radiotherapy: a new arrow in the quiver]Daniel M Aebersold
European Urology|December 16, 2011
Re: Andrew J. Stephenson, Michel Bolla, Alberto Briganti, et al. Postoperative radiation therapy for pathologically advanced prostate cancer after radical prostatectomy. Eur Urol 2012;61:443-51Pirus Ghadjar, Daniel M Aebersold
BMC Bioinformatics|November 11, 2019
ProtRank: bypassing the imputation of missing values in differential expression analysis of proteomic dataMatúš Medo, Daniel M Aebersold, Michaela Medová
International Journal of Cancer|March 15, 2011
MET inhibition in tumor cells by PHA665752 impairs homologous recombination repair of DNA double strand breaksMichaela Medová, Daniel M Aebersold, Yitzhak Zimmer
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 23, 2021
[Virtual prostatectomy using single dose radiotherapy]Mohamed Shelan, Elena Riggenbach, Daniel M Aebersold
Biochemical Pharmacology|August 31, 2016
Senescence as biologic endpoint following pharmacological targeting of receptor tyrosine kinases in cancerPaola Francica, Daniel M Aebersold, Michaela Medová
Cancers|January 1, 2014
The Molecular Crosstalk between the MET Receptor Tyrosine Kinase and the DNA Damage Response-Biological and Clinical AspectsMichaela Medová, Daniel M Aebersold, Yitzhak Zimmer
Journal of Translational Medicine|August 15, 2018
Protocol for serum exosomal miRNAs analysis in prostate cancer patients treated with radiotherapyBijaya Malla, Daniel M Aebersold, Alan Dal Pra
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 21, 2025
[The EMBARK trial: The use of enzalutamide in biochemically recurrent prostate cancer after primary therapy]Mohamed Shelan, Etienne Mathier, Daniel M Aebersold, et al.
Pageof 22

Showing results (1-10 of 214) with videos related to

Sort By:
Pageof 22
Liver International : Official Journal of the International Association for the Study of the Liver|February 5, 2009
Potential and future strategies for radiotherapy in hepatocellular carcinomaDaniel M Aebersold
Praxis|October 17, 2013
[Extracranial stereotactic radiotherapy: a new arrow in the quiver]Daniel M Aebersold
European Urology|December 16, 2011
Re: Andrew J. Stephenson, Michel Bolla, Alberto Briganti, et al. Postoperative radiation therapy for pathologically advanced prostate cancer after radical prostatectomy. Eur Urol 2012;61:443-51Pirus Ghadjar, Daniel M Aebersold
BMC Bioinformatics|November 11, 2019
ProtRank: bypassing the imputation of missing values in differential expression analysis of proteomic dataMatúš Medo, Daniel M Aebersold, Michaela Medová
International Journal of Cancer|March 15, 2011
MET inhibition in tumor cells by PHA665752 impairs homologous recombination repair of DNA double strand breaksMichaela Medová, Daniel M Aebersold, Yitzhak Zimmer
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 23, 2021
[Virtual prostatectomy using single dose radiotherapy]Mohamed Shelan, Elena Riggenbach, Daniel M Aebersold
Biochemical Pharmacology|August 31, 2016
Senescence as biologic endpoint following pharmacological targeting of receptor tyrosine kinases in cancerPaola Francica, Daniel M Aebersold, Michaela Medová
Cancers|January 1, 2014
The Molecular Crosstalk between the MET Receptor Tyrosine Kinase and the DNA Damage Response-Biological and Clinical AspectsMichaela Medová, Daniel M Aebersold, Yitzhak Zimmer
Journal of Translational Medicine|August 15, 2018
Protocol for serum exosomal miRNAs analysis in prostate cancer patients treated with radiotherapyBijaya Malla, Daniel M Aebersold, Alan Dal Pra
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 21, 2025
[The EMBARK trial: The use of enzalutamide in biochemically recurrent prostate cancer after primary therapy]Mohamed Shelan, Etienne Mathier, Daniel M Aebersold, et al.
Pageof 22